Evidence supporting the use of: DIM (diindolylmethane)
For the health condition: PMS Type P
Synopsis
Source of validity: Scientific
Rating (out of 5): 2
Diindolylmethane (DIM) is a compound derived from the digestion of indole-3-carbinol, found in cruciferous vegetables like broccoli and Brussels sprouts. Its use for PMS Type P (premenstrual syndrome with predominant "P" symptoms such as bloating, breast tenderness, and mood swings, which are often linked to estrogen dominance) is primarily based on its purported ability to modulate estrogen metabolism. Scientific interest in DIM stems from its effects on estrogen pathways, specifically promoting the conversion of estradiol to less potent metabolites (2-hydroxyestrone over 16α-hydroxyestrone), theoretically reducing estrogen dominance symptoms. Some small clinical studies and in vitro research suggest DIM may alter estrogen metabolism and possibly reduce symptoms related to high estrogen states, which forms the rationale for its use in PMS Type P. However, direct clinical trials assessing DIM specifically for PMS symptoms are lacking; most evidence is extrapolated from its use in hormone-related conditions (like breast pain or endometriosis) and its biochemical effects on estrogen. Consequently, the evidence base is limited (rated 2 out of 5), with more robust, targeted clinical research needed to confirm efficacy and safety for PMS treatment. Its current use for PMS Type P is supported by a mechanistic rationale and limited human data, rather than strong, direct clinical trial evidence.
Other health conditions supported by DIM (diindolylmethane)
AcneBenign Prostate Hyperplasia
Breast Lumps
Cancer (natural therapy for)
Cancer (prevention)
Cancer Treatment (reducing side effects)
Cervical Dysplasia
Endometriosis
Fibroids (uterine)
Menopause
PMS (general)
PMS Type A
PMS Type D
PMS Type H
PMS Type P
PMS Type S
Prostatitis